Towards therapeutic choices in ulcerative colitis

被引：22
作者：
Laharie, David [1 ]
机构：
[1] Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, F-33600 Bordeaux, France
来源：
LANCET | 2017年 / 390卷 / 10090期
关键词：
MAINTENANCE THERAPY; INDUCTION; VEDOLIZUMAB; TRIAL;
D O I：
10.1016/S0140-6736(17)31263-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：98 / 99
页数：3
相关论文
共 10 条
  • [1] The safety of vedolizumab for ulcerative colitis and Crohn's disease
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Rutgeerts, Paul
    Sandborn, William
    Danese, Silvio
    D'Haens, Geert
    Panaccione, Remo
    Loftus, Edward V., Jr.
    Sankoh, Serap
    Fox, Irving
    Parikh, Asit
    Milch, Catherine
    Abhyankar, Brihad
    Feagan, Brian G.
    [J]. GUT, 2017, 66 (05) : 839 - 851
  • [2] Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
    Feagan, Brian G.
    Rubin, David T.
    Danese, Silvio
    Vermeire, Severine
    Abhyankar, Brihad
    Sankoh, Serap
    James, Alexandra
    Smyth, Michael
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (02) : 229 - +
  • [3] Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Feagan, Brian G.
    Rutgeerts, Paul
    Sands, Bruce E.
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Sandborn, William J.
    Van Assche, Gert
    Axler, Jeffrey
    Kim, Hyo-Jong
    Danese, Silvio
    Fox, Irving
    Milch, Catherine
    Sankoh, Serap
    Wyant, Tim
    Xu, Jing
    Parikh, Asit
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) : 699 - 710
  • [4] The safety of biological pharmacotherapy for the treatment of ulcerative colitis
    Fiorino, Gionata
    Bonovas, Stefanos
    Cicerone, Clelia
    Allocca, Mariangela
    Furfaro, Federica
    Correale, Carmen
    Danese, Silvio
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 437 - 443
  • [5] Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
    Molodecky, Natalie A.
    Soon, Ing Shian
    Rabi, Doreen M.
    Ghali, William A.
    Ferris, Mollie
    Chernoff, Greg
    Benchimol, Eric I.
    Panaccione, Remo
    Ghosh, Subrata
    Barkema, Herman W.
    Kaplan, Gilaad G.
    [J]. GASTROENTEROLOGY, 2012, 142 (01) : 46 - 54
  • [6] Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
    Paramsothy, Sudarshan
    Kamm, Michael A.
    Kaakoush, Nadeem O.
    Walsh, Alissa J.
    van den Bogaerde, Johan
    Samuel, Douglas
    Leong, Rupert W. L.
    Connor, Susan
    Ng, Watson
    Paramsothy, Ramesh
    Xuan, Wei
    Lin, Enmoore
    Mitchell, Hazel M.
    Borody, Thomas J.
    [J]. LANCET, 2017, 389 (10075) : 1218 - 1228
  • [7] Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011
    Rungoe, Christine
    Langholz, Ebbe
    Andersson, Mikael
    Basit, Saima
    Nielsen, Nete M.
    Wohlfahrt, Jan
    Jess, Tine
    [J]. GUT, 2014, 63 (10) : 1607 - 1616
  • [8] Ulcerative colitis
    Ungaro, Ryan
    Mehandru, Saurabh
    Allen, Patrick B.
    Peyrin-Biroulet, Laurent
    Colombel, Jean-Frederic
    [J]. LANCET, 2017, 389 (10080) : 1756 - 1770
  • [9] Vermeire S, 2017, LANCET
  • [10] Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
    Vermeire, Severine
    O'Byrne, Sharon
    Keir, Mary
    Williams, Marna
    Lu, Timothy T.
    Mansfield, John C.
    Lamb, Christopher A.
    Feagan, Brian G.
    Panes, Julian
    Salas, Azucena
    Baumgart, Daniel C.
    Schreiber, Stefan
    Dotan, Iris
    Sandborn, William J.
    Tew, Gaik W.
    Luca, Diana
    Tang, Meina T.
    Diehl, Lauri
    Eastham-Anderson, Jeffrey
    De Hertogh, Gert
    Perrier, Clementine
    Egen, Jackson G.
    Kirby, John A.
    van Assche, Gert
    Rutgeerts, Paul
    [J]. LANCET, 2014, 384 (9940) : 309 - 318
1